Replimune REPL
NASDAQ REPL
$23.28 +1.02 (+4.58%)
At close: Nov 10, 2026 · 4:00 PM EST

Replimune (REPL) Invested Capital (2019 - 2026)

Updated

Replimune's Invested Capital was $304.54 million in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 1.9% from $310.54 million a year earlier but up 60.5% from the prior quarter.

Analysis

Replimune (REPL) Invested Capital (2019 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Invested Capital at Replimune came in at $249.47 million, down 46.0% from FY2025.

  • Invested Capital shows a four-year compound annual growth rate of -11.7% (FY2022 to FY2026).
  • In earlier fiscal years, Invested Capital was $462.22 million in FY2025 (+10.2%), $419.32 million in FY2024 (-28.2%), $583.94 million in FY2023 (+42.0%) and $411.23 million in FY2022.
  • Quarterly Invested Capital has moved between $189.76 million (fiscal Q1 2027) and $623.74 million (fiscal Q3 2023) over five years.
  • Compared with a year earlier, Invested Capital has declined for six straight quarters, with an average decline of 21.5% over the last eight quarters.
  • The best year-over-year quarter for Invested Capital over five years was fiscal Q4 2023 (growth of 42.0%); the worst was fiscal Q3 2026 (a decline of 51.1%).
  • Per Business Quant data, REPL's Invested Capital in the three fiscal quarters before Q2 2027 was $189.76 million (Q1 2027), $249.47 million (Q4 2026) and $258.17 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 89.77 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 126.18 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 76.32 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 98.72 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 51.53 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 82.72 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 68.36 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 39.27 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 151.97 Bn
10 Replimune 2.40 Bn 1.35 Bn - 304.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 304.54 Mn
Jun 30, 2026 189.76 Mn
Mar 31, 2026 249.47 Mn
Dec 31, 2025 258.17 Mn
Sep 30, 2025 310.54 Mn
Jun 30, 2025 383.51 Mn
Mar 31, 2025 462.22 Mn
Dec 31, 2024 528.33 Mn
Sep 30, 2024 427.03 Mn
Jun 30, 2024 471.64 Mn
Mar 31, 2024 419.32 Mn
Dec 31, 2023 465.97 Mn
Sep 30, 2023 494.33 Mn
Jun 30, 2023 542.93 Mn
Mar 31, 2023 583.94 Mn
Dec 31, 2022 623.74 Mn
Mar 31, 2022 411.23 Mn
Sep 30, 2020 271.22 Mn
Jun 30, 2020 287.58 Mn
Mar 31, 2020 193.52 Mn
API Access

Replimune Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=REPL&period=max&api_key=YOUR_API_KEY